Smilegate Investment

Smilegate Investment, established in 1999 in Seoul, South Korea, is a venture capital and private equity firm that has actively supported the growth of over 200 companies since its inception. Originally founded as MVP Capital, the firm has organized and managed more than 30 funds, focusing on a diverse range of sectors including B2B, B2C, media, healthcare, energy, information technology, advanced manufacturing, climate technology, digital health, SaaS, artificial intelligence, big data, e-commerce, financial technology, mobile commerce, clean technology, and life sciences. Smilegate Investment aims to identify and nurture promising growth potential within these industries, contributing to the advancement of the South Korean economy.

Byung-Hwi Ahn

Senior Vice President

Heung-Sun Chang

Senior Vice President

Kyoung-Hwan Kim

Senior Vice President

Young-Kwon Ku

President

Jong-Ho Lee

Senior Vice President

Ki-Mun Nam

CEO

Kimoon Nam

CEO

Jung-In Park

Senior Vice President

Past deals in South Korea

CastingN

Series B in 2024
CastingN Co., Ltd is an online sourcing platform based in Incheon, South Korea, established in 2015. It connects companies with professional subcontractors across various sectors, facilitating the outsourcing of services such as advertising, system development, web design, and accounting. The platform evaluates multiple factors, including company history, performance, and feedback, to identify the most suitable subcontractors for clients' needs. In addition to its matching services, CastingN offers programs for developing job-oriented content and conducting offline job training, enabling companies to work efficiently with specialized service providers.

Habit Factory

Series C in 2023
Habit Factory is a South Korea-based company that specializes in developing application software aimed at analyzing users' consumption patterns. By providing insights into spending habits, the company helps individuals understand their financial behavior and enhance their savings. Additionally, Habit Factory offers financial big data analytics solutions and has created a platform that simplifies the search for insurance policies using basic information such as a phone number or credit card. This platform not only analyzes users' financial data but also delivers personalized information and recommendations, thereby facilitating informed decision-making in financial services.

Bosalpim

Seed Round in 2022
Bosalpim is a supplier of visiting care brokerage services for the elderly. Headquartered in Gangnam-gu, Seoul.

G+FLAS Life Sciences

Series E in 2022
G+FLAS Life Sciences Co., Ltd., founded in 2014 and based in Seoul, South Korea, specializes in agricultural biotechnology with a focus on genome editing applications. Utilizing advanced CRISPR-Cas technology, the company develops innovative products such as glycoengineered humanized plants, which involve the selective removal of glycosylation-related genes. A flagship product is the vitamin D3-enriched tomato, aimed at enhancing nutritional value and addressing market demand for functional foods. This product not only serves the health-conscious consumer but also provides a plant-based alternative to traditional vitamin D supplements, catering to various dietary needs. G+FLAS has established a strategic partnership with Bayer, facilitating the commercialization of its technology and enhancing its position in the agricultural market. The company is also engaged in drug research and development, utilizing its gene therapy expertise to support healthcare organizations and pharmaceutical companies. G+FLAS Life Sciences is well-positioned for growth, targeting significant market share and aiming to accelerate expansion in the U.S. and beyond.

Dr.Diary

Series B in 2022
Dr.Diary is a company that provides a comprehensive diabetes management application aimed at helping users monitor and manage their condition effectively. Founded in 2017 and based in Seoul, South Korea, the application allows users to track their blood glucose levels, exercise routines, and food intake, while offering insights on how these factors influence their health. In addition to these features, the platform includes medicine intake reminders, monthly health reports, and daily tips on diabetes management. It also facilitates communication with friends and provides personal consultation services with healthcare professionals, enhancing the overall user experience in managing diabetes.

Nearthlab

Series C in 2022
Nearthlab, Inc. is a technology-focused start-up based in Seoul, South Korea, specializing in the development of autonomous drone systems primarily for the wind and renewable energy sectors. Founded by graduates of KAIST, the company leverages proprietary deep-learning algorithms to enhance safety inspections. Its flagship products include NearthWIND Pro, an autonomous drone designed for wind turbine inspections that can detect cracks and damages using AI, Zoomable, a cloud-based platform for managing and analyzing inspection data, and NearthWIND Mobile, a mobile solution for autonomous flight control. Nearthlab's AI technology allows for efficient autonomous flight in low-computing power and low-latency conditions, significantly reducing inspection times from hours to minutes. The company is supported by prominent venture capital firms in Korea, positioning it as a leader in drone technology for inspection purposes.

Y-Biologics

Venture Round in 2022
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a unique bispecific antibody platform technology known as AliCE, which retains the structure of the parental antibody to ensure high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL library, which comprises a diverse range of antibodies. The company also offers contract research services, further contributing to its position in the antibody drug market. Through its innovative technologies and research efforts, Y-Biologics aims to advance its portfolio of antibody drugs and strengthen its role in the global immuno-chemotherapeutic landscape.

SWING

Series B in 2022
Swing Co., Ltd. is a South Korean company established in 2018, specializing in the rental of electric kickboards and scooters. The company offers a personal mobility service that allows users to rent electric scooters for commuting purposes. Customers can ride the scooters and park them in designated safe areas that do not obstruct traffic. This service aims to provide a convenient and efficient transportation option for individuals seeking to navigate urban environments using electric scooters, e-bikes, and e-mopeds.

Law&Company

Series C in 2022
Law&Company is representative legal tech company in Republic of Korea. The company provides a service called 'LawTalk(www.lawtalk.co.kr)', which is the largest online legal market place in Korea(5 times bigger then the 2nd player). Since 2016, the company invested on research about Artificial Intelligence especially on Text Mining and Machine Learning technology to analyze lawyers and client's activities in the service which helps to lawyers and clients find the right person based on their experience. Also, the company will launch document automation based service to generate legal documents starting from complaint and contract soon. The company has received more than 3 million dollars from 5 venture capital companies and many angel investors due to previous performance and upside potential in the Korean legal market.

Dealicious

Series C in 2022
Dealicious operates an online marketplace that connects fashion wholesalers in South Korea with retailers around the globe. Specializing in the vibrant Dongdaemun fashion district, it provides access to a vast selection of clothing, bags, shoes, and accessories. The platform features approximately 11,000 registered wholesale stores, allowing retailers to browse and order from an extensive inventory of items, with 24,000 new products added daily. This streamlined service eliminates the need for retailers to visit physical markets, thereby saving time and resources. Dealicious focuses on enhancing the user experience by offering customer-centric services that simplify access to quality Korean fashion products. By facilitating direct interactions between wholesalers and retailers, the company aims to make the wholesale supply chain more efficient and accessible.

Fount

Series C in 2021
Fount Inc. is an asset management Robo-Advisor company established in 2015 and headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its advanced Robo-Advisor engine, Bluewhale, which utilizes AI technology and asset allocation theories to determine the optimal mix of assets. Fount's investing algorithm, driven by big data, assists clients in planning for various life events by promoting passive investing strategies that align with individual risk tolerance and time horizons. The company's tools enable clients to monitor financial markets and adjust their asset allocations in response to market fluctuations.

QANDA(Mathpresso)

Series C in 2021
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.

CLASSUM

Series A in 2021
CLASSUM Co., Ltd., founded in 2017 and based in Seoul, South Korea, operates as an interactive learning platform designed to enhance communication in educational settings. Targeting higher education and workplace learning, CLASSUM employs a user-friendly interface inspired by chat and social networking features to facilitate seamless interaction between students and instructors. The platform utilizes artificial intelligence and big data analysis to generate comprehensive class reports, providing valuable insights that help improve educational outcomes. Additionally, CLASSUM offers features such as real-time surveys, feedback mechanisms, and classroom creation tools, enabling users to engage effectively and empower their learning experiences.

Lemonex

Series C in 2021
Lemonex Inc. is a biotechnology company based in Seoul, South Korea, founded in 2013. It specializes in the development and commercialization of biotherapeutics aimed at treating cancers and other challenging diseases. The company focuses on cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. Lemonex offers innovative drug delivery solutions, including DegradaBALL, which facilitates the delivery of drug candidates into cultured cells and lesions, and PANGO, a technology for the rapid screening of antiviral drugs. Additionally, Lemonex is engaged in advancing biosensor technology, enhancing the effectiveness of drug delivery methods for healthcare professionals.

Bertis

Venture Round in 2020
Bertis Inc. is a proteomics-based molecular diagnostics company focused on developing and commercializing cancer-related biomarkers for early disease detection. Founded in 2014 and based in Seongnam, South Korea, the company offers Mastocheck, a screening method for diagnosing stage 1 breast cancer. Bertis is engaged in extensive research for biomarker development aimed at the early diagnosis of various carcinomas, as well as the creation of new therapeutic markers and co-markers. Utilizing advanced bio-big data analysis technologies, the company seeks to uncover biomarkers across multiple fields by integrating proteomics, genomics, and bioinformatics. Additionally, Bertis is developing an AI-based diagnostic platform to enhance the diagnosis of cancer and cardiac diseases, thereby enabling more effective early detection and treatment options for medical practitioners.

HUINNO

Series B in 2020
HUINNO, Inc., founded in 2014 and headquartered in Boston, Massachusetts, develops healthcare devices that monitor vital health data, including blood pressure, heart rate, electrocardiogram (ECG), and blood oxygen saturation levels (SpO2). The company leverages proprietary technologies in wearable devices and artificial intelligence to provide healthcare providers with an effective remote patient monitoring solution aimed at improving the management of chronic cardiac diseases. HUINNO's clinically-tested platform delivers real-time measurements with clinical-grade accuracy and offers an application and cloud-based ecosystem for longitudinal analysis of health trends, medication compliance, and lifestyle habits. This comprehensive approach not only enhances patient care but also aids healthcare professionals in making informed medical decisions while treating conditions such as arrhythmia and hypertension. With additional offices in New York and Seoul, HUINNO is committed to transforming the way clinicians and patients manage chronic health issues.

Shaperon

Series C in 2020
Shaperon Inc. is a biotechnology company based in Seoul, South Korea, founded in 2008, that specializes in the research and development of innovative therapeutics targeting chronic inflammatory diseases. The company focuses on creating inflammasome inhibitors and nanobody therapeutics designed to address conditions such as atopic dermatitis, systemic inflammatory response syndrome, and neuroinflammatory diseases. Shaperon offers a variety of drug candidates, including a gel-type formulation for treating atopic dermatitis and other related inflammatory conditions. In addition to its drug development efforts, the company is involved in providing immunotherapeutic products, including single-domain neutralizing antibodies, aimed at enhancing the quality of life for patients suffering from chronic inflammation and related ailments.

Bagelcode

Series D in 2020
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, that specializes in developing social casino games. Founded in 2012, the company has built a global presence, attracting over 170 members from various countries, including South Korea, the United States, and the United Kingdom. With more than 45 million users worldwide, Bagelcode focuses on creating an engaging gaming experience that allows players to enjoy casino games like slots and poker on both web and mobile platforms. The company emphasizes the importance of individual growth for collective success, fostering a diverse team of talented professionals from top universities and countries. Since its inception, Bagelcode has demonstrated substantial growth, launching multiple successful titles and continuously seeking new talent to achieve its goal of becoming a leading global gaming company.

Trost

Series A in 2020
Trost, operated by Humart Company Co., Ltd., specializes in mental healthcare services, offering a range of online counseling options. Founded in 2016 and headquartered in Seoul, South Korea, Trost utilizes a mobile application to facilitate consultations between users and licensed counselors, enabling effective diagnosis and treatment. In addition to counseling, the platform provides various self-analysis tests, including psychological assessments, personality evaluations, and stress-related tests. Through its employee assistance program, Trost aims to enhance mental well-being in both individual and workplace settings.

CLASSUM

Venture Round in 2019
CLASSUM Co., Ltd., founded in 2017 and based in Seoul, South Korea, operates as an interactive learning platform designed to enhance communication in educational settings. Targeting higher education and workplace learning, CLASSUM employs a user-friendly interface inspired by chat and social networking features to facilitate seamless interaction between students and instructors. The platform utilizes artificial intelligence and big data analysis to generate comprehensive class reports, providing valuable insights that help improve educational outcomes. Additionally, CLASSUM offers features such as real-time surveys, feedback mechanisms, and classroom creation tools, enabling users to engage effectively and empower their learning experiences.

Raonsecure

Venture Round in 2019
Raonsecure Co., Ltd. is an ICT security software company based in Seoul, South Korea, founded in 1998. It specializes in providing a range of security solutions for PCs and mobile devices, catering to financial institutions, government entities, and enterprises. The company's primary product is TouchEn OnePass, a biometric authentication solution designed for various applications, including payments, mobile banking, shopping, gaming networks, and fintech services. Additionally, Raonsecure offers ICT security consulting services and holds several patents in the IoT and integrated security sectors. The company is focused on advancing authentication technologies, integrating human and device security, and leveraging FIDO standards based on public key infrastructure (PKI) technology.

HUINNO

Series A in 2019
HUINNO, Inc., founded in 2014 and headquartered in Boston, Massachusetts, develops healthcare devices that monitor vital health data, including blood pressure, heart rate, electrocardiogram (ECG), and blood oxygen saturation levels (SpO2). The company leverages proprietary technologies in wearable devices and artificial intelligence to provide healthcare providers with an effective remote patient monitoring solution aimed at improving the management of chronic cardiac diseases. HUINNO's clinically-tested platform delivers real-time measurements with clinical-grade accuracy and offers an application and cloud-based ecosystem for longitudinal analysis of health trends, medication compliance, and lifestyle habits. This comprehensive approach not only enhances patient care but also aids healthcare professionals in making informed medical decisions while treating conditions such as arrhythmia and hypertension. With additional offices in New York and Seoul, HUINNO is committed to transforming the way clinicians and patients manage chronic health issues.

D&D Pharmatech

Series B in 2019
D&D Pharmatech Co., Ltd. is a clinical-stage global biotech company based in Seongnam, South Korea, founded in 2014. The company focuses on developing therapeutic medicines for various indications, including neurodegenerative diseases, metabolic disorders, fibrotic diseases, and molecular imaging and radiotherapy. D&D Pharmatech operates as a holding company, funding the development of disease-specific subsidiaries led by esteemed medical research faculty. Its product pipeline aims to translate advanced research into effective therapeutic solutions. The company also engages in specialized projects such as developing positron emission tomography (PET) imaging biomarkers through its subsidiary, Precision Molecular Inc., and single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. D&D Pharmatech employs innovative drug delivery technologies, including PEGylation, to enhance treatment efficacy and patient outcomes.

G+FLAS Life Sciences

Series C in 2019
G+FLAS Life Sciences Co., Ltd., founded in 2014 and based in Seoul, South Korea, specializes in agricultural biotechnology with a focus on genome editing applications. Utilizing advanced CRISPR-Cas technology, the company develops innovative products such as glycoengineered humanized plants, which involve the selective removal of glycosylation-related genes. A flagship product is the vitamin D3-enriched tomato, aimed at enhancing nutritional value and addressing market demand for functional foods. This product not only serves the health-conscious consumer but also provides a plant-based alternative to traditional vitamin D supplements, catering to various dietary needs. G+FLAS has established a strategic partnership with Bayer, facilitating the commercialization of its technology and enhancing its position in the agricultural market. The company is also engaged in drug research and development, utilizing its gene therapy expertise to support healthcare organizations and pharmaceutical companies. G+FLAS Life Sciences is well-positioned for growth, targeting significant market share and aiming to accelerate expansion in the U.S. and beyond.

Law&Company

Series B in 2019
Law&Company is representative legal tech company in Republic of Korea. The company provides a service called 'LawTalk(www.lawtalk.co.kr)', which is the largest online legal market place in Korea(5 times bigger then the 2nd player). Since 2016, the company invested on research about Artificial Intelligence especially on Text Mining and Machine Learning technology to analyze lawyers and client's activities in the service which helps to lawyers and clients find the right person based on their experience. Also, the company will launch document automation based service to generate legal documents starting from complaint and contract soon. The company has received more than 3 million dollars from 5 venture capital companies and many angel investors due to previous performance and upside potential in the Korean legal market.

Orum Therapeutics

Series B in 2019
Orum Therapeutics is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of therapeutic antibodies through its innovative cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's unique approach allows for the intracellular delivery of active antibody therapeutics or payloads, enabling the inhibition of drug targets that have been previously considered undruggable by conventional small molecules or antibody therapies. Orum's technology is adaptable to various cell types and intracellular proteins without requiring chemical modifications, aiming to develop effective treatments with improved specificity and reduced toxicity.

Wadiz

Series C in 2019
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.

Dealicious

Series B in 2019
Dealicious operates an online marketplace that connects fashion wholesalers in South Korea with retailers around the globe. Specializing in the vibrant Dongdaemun fashion district, it provides access to a vast selection of clothing, bags, shoes, and accessories. The platform features approximately 11,000 registered wholesale stores, allowing retailers to browse and order from an extensive inventory of items, with 24,000 new products added daily. This streamlined service eliminates the need for retailers to visit physical markets, thereby saving time and resources. Dealicious focuses on enhancing the user experience by offering customer-centric services that simplify access to quality Korean fashion products. By facilitating direct interactions between wholesalers and retailers, the company aims to make the wholesale supply chain more efficient and accessible.

Vuno

Series B in 2018
Vuno offers artificial intelligence-based medical solutions for doctors and patients that provides a platform and consulting services for medical data analysis. Vuno develops automatic algorithm against various problems that occurs in medical sites as well as it develops diagnostic and quantification assisting software. The clients of the company are Asan Medical Center and HYUNDAI. The company offers VunoMed that provides different forms of data analyzation for medical videos, ECGs, brain waves, and EMR data. Vuno is located in South Korea and the company was founded in 2014 by Yeha Lee, Kyu-Hwan Jung, and Dannis Kim.

Wishket

Venture Round in 2018
Wishket Co., Ltd. is an IT outsourcing platform based in Seoul, South Korea, established in 2012. It facilitates the connection between companies and freelancers by allowing them to post projects and search for job opportunities online. The platform offers a secure and cost-effective way for companies to find suitable freelancers for development work. By enabling companies to post projects and receive responses from freelancers, Wishket streamlines the outsourcing process. Additionally, it provides freelancers with access to new projects and opportunities. The platform is designed to minimize transaction costs and trust issues commonly associated with IT project outsourcing, thanks to its private application and escrow system, which enhances the overall efficiency of the contracting process.

Bagelcode

Series C in 2018
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, that specializes in developing social casino games. Founded in 2012, the company has built a global presence, attracting over 170 members from various countries, including South Korea, the United States, and the United Kingdom. With more than 45 million users worldwide, Bagelcode focuses on creating an engaging gaming experience that allows players to enjoy casino games like slots and poker on both web and mobile platforms. The company emphasizes the importance of individual growth for collective success, fostering a diverse team of talented professionals from top universities and countries. Since its inception, Bagelcode has demonstrated substantial growth, launching multiple successful titles and continuously seeking new talent to achieve its goal of becoming a leading global gaming company.

Life Semantics

Corporate Round in 2018
Life Semantics (라이프시맨틱스) is a Korean specialty engineering company focused on developing software platforms and systems for the medical industry. It develops Hospital Information Systems (HIS) and semantic web technology for application in the area of life sciences. The company looks to resolve common problems faced by healthcare facilities and researchers by providing automation software. HIS is a fully integrated information system providing healthcare organizations with a full suite of tools for improved hospital management, clinical tasks, and patient administration.

Syntekabio

Series B in 2018
Syntekabio, Inc. is a bioinformatics company based in Daejeon, South Korea, founded in 2009. It specializes in managing and analyzing genomic data through advanced algorithms and artificial intelligence. The company develops personal genome maps that serve as comprehensive resources for disease prevention and tailored drug development. Additionally, it offers genome data integration services and operates a supercomputer known as MAHA, which enhances data processing efficiency for genome-based diagnostics. Syntekabio also focuses on collecting and integrating decrypted whole genome data for various applications, including the analysis of rare diseases and genetic relationships, by sequencing blood samples from diverse populations worldwide.

D&D Pharmatech

Series A in 2018
D&D Pharmatech Co., Ltd. is a clinical-stage global biotech company based in Seongnam, South Korea, founded in 2014. The company focuses on developing therapeutic medicines for various indications, including neurodegenerative diseases, metabolic disorders, fibrotic diseases, and molecular imaging and radiotherapy. D&D Pharmatech operates as a holding company, funding the development of disease-specific subsidiaries led by esteemed medical research faculty. Its product pipeline aims to translate advanced research into effective therapeutic solutions. The company also engages in specialized projects such as developing positron emission tomography (PET) imaging biomarkers through its subsidiary, Precision Molecular Inc., and single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. D&D Pharmatech employs innovative drug delivery technologies, including PEGylation, to enhance treatment efficacy and patient outcomes.

Wadiz

Series B in 2017
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.

Wadiz

Series A in 2017
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.

Bagelcode

Series B in 2017
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, that specializes in developing social casino games. Founded in 2012, the company has built a global presence, attracting over 170 members from various countries, including South Korea, the United States, and the United Kingdom. With more than 45 million users worldwide, Bagelcode focuses on creating an engaging gaming experience that allows players to enjoy casino games like slots and poker on both web and mobile platforms. The company emphasizes the importance of individual growth for collective success, fostering a diverse team of talented professionals from top universities and countries. Since its inception, Bagelcode has demonstrated substantial growth, launching multiple successful titles and continuously seeking new talent to achieve its goal of becoming a leading global gaming company.

Vuno

Series A in 2016
Vuno offers artificial intelligence-based medical solutions for doctors and patients that provides a platform and consulting services for medical data analysis. Vuno develops automatic algorithm against various problems that occurs in medical sites as well as it develops diagnostic and quantification assisting software. The clients of the company are Asan Medical Center and HYUNDAI. The company offers VunoMed that provides different forms of data analyzation for medical videos, ECGs, brain waves, and EMR data. Vuno is located in South Korea and the company was founded in 2014 by Yeha Lee, Kyu-Hwan Jung, and Dannis Kim.

Fount

Series A in 2016
Fount Inc. is an asset management Robo-Advisor company established in 2015 and headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its advanced Robo-Advisor engine, Bluewhale, which utilizes AI technology and asset allocation theories to determine the optimal mix of assets. Fount's investing algorithm, driven by big data, assists clients in planning for various life events by promoting passive investing strategies that align with individual risk tolerance and time horizons. The company's tools enable clients to monitor financial markets and adjust their asset allocations in response to market fluctuations.

Stripes

Series B in 2015
Stripes is a Korea-based apparel company that designs and manufactures men’s clothing products. Stripes’ clothing collection carries directional designs, as well as every day favorites including, t-shirts, shirts, and suits. The company also provides personalized styling services, enabling customers to personalize their clothes and have them designed to a perfect fit. Stripes markets its product through the web and mobile medium, giving consumers the facility of buying clothes at the comfort of their homes. Stripes was established in January 2013.

Wishket

Series A in 2015
Wishket Co., Ltd. is an IT outsourcing platform based in Seoul, South Korea, established in 2012. It facilitates the connection between companies and freelancers by allowing them to post projects and search for job opportunities online. The platform offers a secure and cost-effective way for companies to find suitable freelancers for development work. By enabling companies to post projects and receive responses from freelancers, Wishket streamlines the outsourcing process. Additionally, it provides freelancers with access to new projects and opportunities. The platform is designed to minimize transaction costs and trust issues commonly associated with IT project outsourcing, thanks to its private application and escrow system, which enhances the overall efficiency of the contracting process.

NBT

Series B in 2015
NBT Partners is a South Korean company established in 2012, specializing in mobile and online platform development services. The company offers a range of products, including Cache Slides, an application designed to verify information during shopping activities through a slide unlock screen, and Baobab Class, an online platform that delivers personalized educational content. Additionally, NBT provides a mobile application that features a customized accumulation system and leverages knowledge-based technology to cater to users' preferences.

Parking Square

Series A in 2015
Parking Square Inc provides smart mobile solutions and services for parking services in Korea. It provides solutions for real time parking services involving booking and discounts. Parking Square Inc provides an application known as Park Here, which allows users to find, locate, and book parking spaces at discounted rates. Parking Square is available as an iOS and Android app. It also enables garage owners and operators to promote and rent out their idle parking space. The company was established on May 7, 2013, based in Seoul, Korea.

Stripes

Series A in 2014
Stripes is a Korea-based apparel company that designs and manufactures men’s clothing products. Stripes’ clothing collection carries directional designs, as well as every day favorites including, t-shirts, shirts, and suits. The company also provides personalized styling services, enabling customers to personalize their clothes and have them designed to a perfect fit. Stripes markets its product through the web and mobile medium, giving consumers the facility of buying clothes at the comfort of their homes. Stripes was established in January 2013.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.